Header cover image

Pharmaceuticals & Biotech Top Rated Asian Stocks

Results

14

1 new

Financially healthy companies listed on Asian stock exchanges with an impressive track record.

14 companies

Laurus Labs

Market Cap: ₹980.5b

Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.

LAURUSLABS

₹1,816.20

7D

13.4%

1Y

113.8%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$47.0b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$50.15

7D

-3.7%

1Y

97.1%

Anthem Biosciences

Market Cap: ₹455.7b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

ANTHEM

₹809.20

7D

5.1%

1Y

9.6%

Emcure Pharmaceuticals

Market Cap: ₹371.6b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

New

EMCURE

₹1,960.10

7D

4.2%

1Y

43.7%

Acutaas Chemicals

Market Cap: ₹254.2b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACUTAAS

₹3,104.90

7D

-4.7%

1Y

139.5%

Rubicon Research

Market Cap: ₹245.6b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

RUBICON

₹1,491.00

7D

-1.9%

1Y

n/a

Neuland Laboratories

Market Cap: ₹244.6b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

524558

₹19,067.60

7D

2.7%

1Y

46.2%

Aether Industries

Market Cap: ₹204.3b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

AETHER

₹1,539.60

7D

7.9%

1Y

104.3%

Granules India

Market Cap: ₹204.2b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

532482

₹824.05

7D

-1.2%

1Y

82.4%

Inner Mongolia Furui Medical Science

Market Cap: CN¥12.0b

Inner Mongolia Furui Medical Science Co., Ltd.

300049

CN¥45.38

7D

7.5%

1Y

3.8%

Shilpa Medicare

Market Cap: ₹119.6b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

530549

₹611.55

7D

0.7%

1Y

42.7%

Viyash Scientific

Market Cap: ₹110.0b

Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.

512529

₹252.05

7D

0.4%

1Y

49.7%

Strides Pharma Science

Market Cap: ₹94.5b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

STAR

₹1,025.00

7D

0.5%

1Y

22.5%

Sakar Healthcare

Market Cap: ₹19.7b

Research, develops, manufactures, and sells pharmaceutical products in India.

SAKAR

₹885.25

7D

10.4%

1Y

158.2%